Fig. 1: Downregulation of miR-143-3p is correlated with poor clinical outcomes in GBC patients. | Cell Death & Disease

Fig. 1: Downregulation of miR-143-3p is correlated with poor clinical outcomes in GBC patients.

From: miR-143-3p targeting of ITGA6 suppresses tumour growth and angiogenesis by downregulating PLGF expression via the PI3K/AKT pathway in gallbladder carcinoma

Fig. 1

a A portion of the cluster analysis of the miRNA expression profiles of the GBC tissues and NAT counterparts from our previous microarray results. b Scatterplots of the relative expression levels of miR-143-3p in the GBC tissues and their corresponding NATs. miR-143-3p expression was calculated and expressed as the miR-143-3p/U6 expression ratio (2−ΔCT). P = 0.0021. c Comparison of the miR-143-3p expression levels between the GBC tissues and their corresponding NATs. d Kaplan−Meier overall survival curve of GBC patients based on miR-143-3p expression. P < 0.001

Back to article page